DANIELLE KUHN: Open Payments
NPI 1831540293 · AKRON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,379 in 75 payments from 24 companies in 2025. Trend: 2023 $348 · 2024 $812 · 2025 $1,379
Food & beverage: $1,379
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $227 |
| ABBVIE INC. | 13 | $194 |
| Gilead Sciences, Inc. | 4 | $190 |
| Novo Nordisk Inc | 13 | $138 |
| Astellas Pharma US Inc | 2 | $64 |
| Abbott Laboratories | 3 | $64 |
| Exact Sciences Corporation | 3 | $60 |
| Phathom Pharmaceuticals, Inc. | 4 | $56 |
| GlaxoSmithKline, LLC. | 3 | $53 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $43 |
Products named: VRAYLAR, Yeztugo, AIRSUPRA, BREZTRI, Ozempic, Veozah, Cologuard Collection Kit, VOQUEZNA.
Industry payments across OH — which companies pay providers there.
